Progressive Radio Network

LOA Daily

The Gary Null Show Notes - 03.02.21

  1. Chris Hedges: The Age of Social Murder

  2. New GM technology has no place in sustainable farming

  3. Annual Flu Deaths Scam Unwittingly Exposed and Replaced by the COVID Deaths Scam

  4. Within a Matter of Months, the Fed’s Balance Sheet Will Hit $8 Trillion; These Charts Tell the Rest of the Story

  5. American Institute for Economic Research

  6. HERE’S NO 1 SUSTAINABLE FUTURE FOR A DIVERSE WORLD

    Zinc could be key to new diabetes treatments

    University of St Andrews (Scotland), March 1, 2021

    Researchers at the University of St Andrews say a greater understanding of how zinc is handled in our body could lead to improved treatments for people with diabetes.

    The team of scientists, funded by the British Heart Foundation (BHF), have been investigating the causes of potentially  and why these more commonly occur in people with diabetes.

    Diabetes is a major risk factor for  and circulatory diseases. Around 300,000 adults have been diagnosed with diabetes in Scotland and it is estimated that thousands more people have undiagnosed type 2 diabetes.

    Because of the damage it causes to the , people with diabetes are up to three times more likely to develop conditions like heart attacks, stroke and vascular dementia.

    Researchers, led by Dr. Alan Stewart of the School of Medicine at the University of St Andrews, have been looking at the role of  in these processes. Zinc is an essential nutrient that serves many functions in the body. One of its functions is to help the  clot after injury.

    However, in some people with underlying health conditions, such as those with type 2 diabetes or obesity, clotting can occur more often when it’s not required, causing damage to blood vessels and leading to serious  such as stroke and thrombosis (DVT).

    The research, published in Chemical Science, found that the transportation of zinc in the blood is compromised in those with type 2 diabetes due to the increased levels of fatty acids. These fatty acids prevent zinc being carried in the normal way allowing zinc to interact with clot-activating proteins and potentially triggering dangerous blood clots.

    Although further research is needed, they believe their study identifies a new way that vascular problems can occur in certain individuals.

    Principal investigator and Senior Lecturer, Dr. Stewart, said: “Our research suggests that by altering how zinc is handled, elevated levels of fatty acids in the circulation can contribute to the formation of unwanted and potentially dangerous blood clots.

    “Ultimately, we hope that these findings will aid the development of new therapeutic strategies to reduce vascular disease risk in patients with type 2 , as well as other diseases associated with high levels of plasma fatty acids.

    The BHF is the largest independent funder of research into heart and circulatory diseases in the UK and this project is one of thousands funded by the BHF to help save and improve lives.

    James Jopling, head of BHF Scotland, said: “Diabetes is a major risk factor for heart attacks and strokes—conditions which can severely affect quality of life.

    “As such, it is vital we understand more about it and how to treat it. Research projects like this one in St Andrews help inform how we treat patients, identify those at particular risk and ultimately find new ways to save and improve lives.”

     
     

    SAMe shows promise against breast cancer

    McGill University (Montreal), February 23 2021. 

    A research paper published in Oncotarget reveals protective effects for S-adenosylmethionine (SAM or SAMe) against cancer growth, invasion and metastasis in human breast cancer cells and in a mouse model of the disease.

    “We and others have shown that several key molecules implicated in the metastatic cascade are epigenetically regulated through DNA hypomethylation,” Niaz Mahmood and colleagues. “The universal methyl donor SAM could be used in this regard as an inhibitor of demethylation/hypomethylation.

    By testing the effects of two concentrations of SAM on two highly invasive human breast cancer cell lines, a reduction in tumor cell proliferation was observed in comparison to cells treated with an inert substance. In contrast, normal human breast cells treated with the highest concentration of SAMe did not show any change in viability compared to the control cells, indicating a lack of potential adverse effects in healthy tissue. Treatment with SAM was also found to decrease the migratory ability and invasiveness of both cell lines. Further investigation determined that SAM induced apoptosis (programmed cell death) in both lines by suppressing antiapoptotic effects.

    In mice that received implanted human breast tumor cells, tumor volume and metastasis were reduced in association with treatment with SAM. S-adenosylmethionine was also associated with a decrease in the expression of genes implicated in cancer metastasis and progression in breast tumor grafts as well as cancer cells.

    “To our knowledge, this is the first direct evidence for the potential therapeutic effect of SAM in a well-recognized model of breast cancer,” the authors announce. “Results from these studies provide compelling evidence to evaluate the therapeutic as well as a chemopreventive potential of epigenetic-based agents such as SAM alone and in the combination setting for patients with several common cancers including breast cancer.”

     

    The Antidepressant Effects of Lavender: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials

    Tehran University of Medical Sciences (Iran), February 18, 2021

    Antidepressant drugs are accompanied with high rate of adverse effects. Lavender is one of the most common herbal drugs mentioned in Traditional Persian literature with potential efficacy on mental disorders and less serious side effects. Thus, the aim of this study was to determine the efficacy of lavender on depression severity by preforming a systematic review and meta-analysis.

    Methods

    Databases including PubMed, Scopus, Cochrane library, Embase and Web of science were searched for relevant articles till December 2020. Quality of studies were evaluated by Jadad scale and the Cochrane collaboration tool. Depression as endpoint measure or as a subscale of any valid assessment tool was subjected to quantitative data analyses. Both fixed and random effects meta-analysis were conducted for data synthesis.

    Results

    Out of 342 screened studies, 17 articles were included in the meta-analysis. Results showed significant efficacy of lavender in decreasing depression scores compared to the control group (pooled Standardized Mean Difference (SMD)= -0.66, 95% CI: -0.85 to -0.46;P < 0.001, I2 = 68.2%;). Subgroup analysis proved that the effect of lavender was marginally more pronounced in participants with diagnosed depression (pooled SMD= -0.62, 95% CI: -1.26 to 0.01, P = 0.055; I2 = 88.1 %) while its effect was statistically significant in patients having other diseases with concomitant depressive symptoms (pooled SMD= -0.65, 95% CI: -1.84 to -0.46, P < 0.001; I2 = 52.1%), and the oral route (pooled SMD= -0.56, 95% CI: -1.07 to -0.05, P = 0.032; I2 = 85.2%;) was the most effective route of administration.

    Conclusions

    This systematic review and meta-analysis concluded that lavender has significant antidepressant effects. However, due to some limitations, further large clinical trials are recommended with more homogeneous populations and rigorous designs.

    Fish, cruciferous vegetables, olives and more associated with longer telomeres in preschool children

    Sabzevar University of Medical Sciences (Iran), February 26, 2021

    According to news reporting from Sabzevar, Iran, research stated, “Telomere length (TL) has been associated with lifestyle and dietary pattern. However, the available evidence on this association in children is scarce, especially in low- and middle-income countries (LMICs).”

    The news correspondents obtained a quote from the research from the Sabzevar University of Medical Sciences, “Therefore, this study aimed to evaluate the association of dietary pattern and leukocyte TL (LTL) in preschool children, Sabzevar, Iran (2017). This cross-sectional study was based on 187 preschool children (aged 5 to 7) recruited from 27 kindergartens. Nutrition information including amounts of consumed dairy products, meat and processed meat products, nuts and seeds, white bread and refined grains, fruits, vegetables, simple sugars, fats and drinks was obtained through a questionnaire. Linear mixed-effects models were fitted with polymerase chain reaction (PCR) plate ID and kindergartens as random effects to estimate the association of each food group consumption with LTL, controlled for relevant covariates. Higher consumption of dairy products and sugar was associated with shorter LTL (b = -0.180, 95% confidence interval [CI]: -0.276, -0.085, P value <0.001 and b = -0.139, 95% CI: -0.193, -0.086, P value <0.001, respectively). An increase in consumption of fish, nuts and seeds, coloured fruits, green leafy vegetables, cruciferous vegetables and olive was significantly associated with the increase in relative LTL. The associations for the consumption of legumes, other fruits, yellow and orange vegetables, red meat, egg, white bread and refined grains, solid and liquid fats, processed meats, potato chips, carbonated drinks, tea (black) and soft drinks groups were not statistically significant.”

    According to the news reporters, the research concluded: “Our findings showed that there was an association between the consumption of certain food groups with LTL.”

    Low-quality maternal diet during pregnancy may be associated with late-childhood obesity

    University College Dublin (Ireland), February 19, 2021

    Eating a low quality diet, high in foods and food components associated with chronic inflammation, during pregnancy may be associated with an increased risk of obesity and excess body fat in children, especially during late-childhood. The findings are published the open access journal BMC Medicine.

    Researchers from University College Dublin, Ireland found that children of mothers who ate a higher quality diet, low in inflammation-associated foods, during pregnancy had a lower risk of obesity and lower body fat levels in late-childhood than children whose mothers ate a lower quality diet, high in inflammation-associated foods, while pregnant. This association was not observed in early or mid-childhood. 

    Ling-Wei Chen, the corresponding author said: “Obesity in childhood often carries on into adulthood and is associated with a higher risk of chronic diseases, including type 2 diabetes. Mounting evidence suggests that maternal diet influences pregnancy and birth outcomes and points to the first one thousand days of a child’s life, from conception to two years old, as a critical period for preventing childhood obesity. Our research indicates that children born to mothers who eat a low-quality diet, high in inflammation-associated foods, during pregnancy may be more likely to have obesity or excess body fat in late childhood than those born to mothers who eat a high-quality diet low in inflammation-associated foods.”

    To examine the effects of maternal diet on the likelihood of childhood obesity and excess body fat, the authors analysed data collected from 16,295 mother-child pairs in seven European birth cohort studies, from Ireland, France, United Kingdom, Netherlands and Poland, which are involved in the ALPHABET consortium. On average, mothers were 30 years old and had a healthy BMI. Mothers reported the food they ate before and during pregnancy. The researchers assessed dietary quality and whether diets were high in foods and food components associated with chronic inflammation, such as saturated fat, refined carbohydrates and red and processed meat. Children’s BMI was calculated in early, mid and late childhood. Additional data on children’s body composition during mid or late childhood was collected in five of the cohorts included in the study.

    The researchers found that children born to mothers who ate diets high in foods associated with inflammation throughout pregnancy tended to have lower levels of fat-free body mass, indicating lower levels of muscle mass, in late-childhood than those whose mothers ate diets low in inflammation-associated foods. Previous research has found that low levels of muscle mass may be associated with a higher risk of combined diabetes, high blood pressure and obesity 

    An association between a lower quality maternal diet, high in inflammation-associated foods, and lower levels of fat-free body mass in late-childhood was found to be stronger in boys than in girls. An association between lower quality maternal diet, high in inflammation-associated foods, and higher body fat levels in mid-childhood was stronger in girls than in boys.

    Catherine Phillips, the principal investigator and coordinator of the ALPHABET project said: “Previous research has suggested that lower maternal carbohydrate intake in early pregnancy can induce epigenetic changes – that is changes which alter gene expression – in children that may be associated with an increased risk of obesity. We propose that a lower quality maternal diet, high in inflammation-associated foods, may similarly induce epigenetic changes and that this may increase the risk of children having obesity or excess body fat in later childhood. Our findings suggest that promoting an overall healthy diet, high in fruit and vegetables and low in refined carbohydrates and red and processed meats, throughout pregnancy may help prevent childhood obesity.”

    The authors caution that the observational nature of the study does not allow for conclusions about a causal relationship between maternal diet and childhood obesity and excess body fat. Future research should account in more detail for other factors that could influence the risk of obesity in childhood, such as childhood physical activity and diet, according to the authors.

    Decreased CoQ10 levels associated with greater lung cancer risk

    Vanderbilt University, February 26 2021. 

    A report appearing on February 6, 2021 in Cancer Medicinedocumented an increase in the risk of lung cancer among members of a low income population in the U.S. Southeast who had decreased plasma levels of CoQ10, a coenzyme involved in the body’s production of energy.

    The study included 596 participants in the Southern Community Cohort Study (SCCS), which enrolled men and women residing in the southern United States who were recruited by mail or from Community Health Centers that served low-income households. A high percentage of participants had less than 12 years of schooling. Seventy-two percent of those with lung cancer were current smokers compared to 41.8% of the controls. 

    Two hundred one participants with lung cancer were matched with 395 control subjects who did not have the disease. Blood samples collected upon enrollment were analyzed for plasma CoQ10.

    A median 973 nanograms per milliliter (ng/mL) of CoQ10 was measured in the plasma of men and women with lung cancer in comparison with 1,076 ng/mL among those who did not have the disease. Among those whose CoQ10 levels were among the top one-third of participants, there was a 40% lower adjusted risk of lung cancer in comparison with having a level among the lowest third. Further analysis found a significant inverse association between CoQ10 concentrations and the risk of lung cancer in current smokers. 

    “In this first prospective case-control study nested within the SCCS, we found an inverse association between plasma CoQ10 and lung cancer risk, particularly in cases diagnosed within one year following blood collection,” Chris Shidal of Vanderbilt University and colleagues wrote. “This association was also more apparent in individuals currently smoking. “These data may provide initial evidence of the utility of circulating CoQ10 level as a biomarker for lung cancer,” they concluded.

    Study finds changes in gut microbiome connected to Alzheimer’s-like behavior

    Oregon Health & Science University, February 26, 2021

    New research in mice published today in the journal Scientific Reports strengthens the growing scientific consensus regarding the role of the gut microbiome in neurodegenerative disorders including Alzheimer’s disease.

    The study, led by researchers at Oregon Health & Science University, found a correlation between the composition of the gut microbiome and the behavioral and cognitive performance of mice carrying genes associated with Alzheimer’s. The mice carried the human amyloid precursor protein gene with dominant Alzheimer’s mutations generated by scientists in Japan.

    The study further suggests a relationship between microbes in the digestive tract and the expression of genes that trigger Alzheimer-like symptoms in mice.

    “You know the expression, ‘You are what you eat?'” said senior author Jacob Raber, Ph.D., professor of behavioral neuroscience in the OHSU School of Medicine. “This may be part of that. While all mice were fed the same diet, the gut microbiome is affected in a genotype-dependent fashion and this in turn might affect your brain.”

    The findings are the first to demonstrate a direct connection between the gut microbiome and cognitive and behavioral changes in an Alzheimer’s disease animal model, and they are consistent with a recently published observational study in people newly diagnosed with Alzheimer’s. In fact, a U.S. clinical trial for the treatment of mild to moderate Alzheimer’s disease is currently underway involving a compound that targets microbes in the gut.

    The research published today breaks new ground.

    In addition to the cognitive and behavioral changes that were measured, the study is the first to demonstrate a relationship between changes in the gut microbiome and epigenetic changes in neural tissue in the hippocampus, an area of the brain affected in Alzheimer’s. This type of research is not possible in people.

    The microbiome is a complex assemblage of microorganisms such as bacteria that play a critical role in a wide range of functions in the body. In this case, researchers wanted to see if the gut microbiome affected cognitive and behavioral measures in specially bred mice at 6 months of age. So they compared wild-type mice with those genetically engineered to carry the human amyloid precursor protein gene with dominant Alzheimer’s mutations.

    They found changes in the gut microbiome – measured in fecal pellets – corresponded with epigenetic regulation of the apolipoprotein E and Tomm40 genes, both associated with Alzheimer’s. They found a clear correlation, but they still can’t say whether one causes the other.

    “Microbes may elicit an impact on behavioral and cognitive measures relevant to Alzheimer’s disease via epigenetic changes in the hippocampus,” Raber said. “Or, alternatively, it might be that the epigenetic changes in the hippocampus affect changes in the gut microbiome.”

    The next phase of research will determine whether it’s possible to reduce Alzheimer’s-like symptoms in genetically predisposed mice by altering their diet.

    “The exciting part of this is that you can manipulate the gut microbiome,” Raber said. “We can use probiotics and see what the effect is.”